Genetic Technologies (GENE) Surges on University of Melbourne Development Agreement

November 29, 2016 9:42 AM EST
Get Alerts GENE Hot Sheet
Trade GENE Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Genetic Technologies (NASDAQ: GENE) is surging 70% off the open after the company announced the signing of an exclusive worldwide license agreement with The University of Melbourne for the development and commercialisation of a novel colorectal cancer (CRC) risk assessment test.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment